Electronic prescribing systems were supposed to eliminate medication errors, yet dangerous discrepancies persist when patients transition from home medications to hospital care. This reality affects millions of hospital admissions annually, where incomplete medication histories can trigger adverse events, prolonged stays, and preventable harm.
A matched cohort study across multiple hospital sites compared 120 patients receiving collaborative pharmacist prescribing against 120 patients under traditional physician-only prescribing. The pharmacist-led approach demonstrated a 96% reduction in undocumented medication discrepancies (relative risk 0.04). These discrepancies represent gaps between patients' actual home medications and what gets prescribed during admission—a critical vulnerability point where therapeutic regimens can be inadvertently altered or discontinued.
The findings challenge the assumption that electronic systems alone solve medication safety. While electronic prescribing platforms streamline workflow, they cannot replace clinical expertise in medication reconciliation—the complex process of verifying, clarifying, and translating a patient's complete medication regimen into hospital orders. Pharmacists bring specialized training in drug interactions, dosing adjustments, and therapeutic equivalencies that physicians, despite their clinical expertise, may lack depth in given their broader scope of practice. This represents a compelling argument for expanding collaborative prescribing models beyond isolated pilot programs. However, the study's limitation to a single healthcare system raises questions about generalizability across different institutional cultures, staffing models, and patient populations. The medication safety crisis demands systematic solutions, and this evidence suggests pharmacist integration into prescribing workflows could be transformative.